Works matching IS 11738804 AND DT 2020 AND VI 34 AND IP 2

Results: 13
    1
    2
    3

    Anti-HIV-1 Antibodies: An Update.

    Published in:
    BioDrugs, 2020, v. 34, n. 2, p. 121, doi. 10.1007/s40259-020-00413-2
    By:
    • Promsote, Wanwisa;
    • DeMouth, Megan E.;
    • Almasri, Cassandra G.;
    • Pegu, Amarendra
    Publication type:
    Article
    4
    5

    Pharmacokinetic Similarity and Comparative Pharmacodynamics, Safety, Efficacy, and Immunogenicity of DRL_RI Versus Reference Rituximab in Biologics-Naïve Patients with Moderate-to-Severe Rheumatoid Arthritis: A Double-Blind, Randomized, Three-Arm Study

    Published in:
    BioDrugs, 2020, v. 34, n. 2, p. 183, doi. 10.1007/s40259-020-00406-1
    By:
    • Haridas, Vikram Muralidhar;
    • Katta, Rahul;
    • Nalawade, Ajit;
    • Kharkar, Sandeep;
    • Zhdan, Vyacheslav;
    • Garmish, Olena;
    • Lopez-Lazaro, Luis;
    • Batra, Sonica Sachdeva;
    • Kankanwadi, Suresh
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13

    Long-term Efficacy, Safety, and Immunogenicity of the Infliximab (IFX) Biosimilar, PF-06438179/GP1111, in Patients with Rheumatoid Arthritis After Switching from Reference IFX or Continuing Biosimilar Therapy: Week 54–78 Data From a Randomized, Double-Blind, Phase III Trial

    Published in:
    BioDrugs, 2020, v. 34, n. 2, p. 197, doi. 10.1007/s40259-019-00403-z
    By:
    • Cohen, Stanley B.;
    • Radominski, Sebastiao C.;
    • Kameda, Hideto;
    • Kivitz, Alan J.;
    • Tee, Michael;
    • Cronenberger, Carol;
    • Zhang, Min;
    • Hackley, Sarah;
    • Rehman, Muhammad I.;
    • von Richter, Oliver;
    • Alten, Rieke
    Publication type:
    Article